Security key
35104E100
4D Molecular Therapeutics, Inc. - Common Stock, $0.0001 par value per share (FDMT)
CUSIP: 35104E100
Q1 2024 13F Holders as of 31 Mar 2024
- Security type / class
- Equity / Common Stock, $0.0001 par value per share
- Total 13F shares
- 56,228,706
- Total 13F value
- $1,790,823,856
- Share change
- +13,806,956
- Put/Call ratio
- 51%
- SEC-reported price per share
- $31.86
- Number of holders
- 146
- Value change
- +$449,592,828
- Number of buys
- 101
- Number of sells
- 54
- Shares outstanding
- 51,571,939
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2024
Institutions
146
Top holders
10
FDMT full security history
Ownership snapshot
Full 13F holder table
4D Molecular Therapeutics, Inc. SEC filings
4D Molecular Therapeutics, Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of FDMT - 4D Molecular Therapeutics, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
VIKING GLOBAL INVESTORS LP
Disclosed value leader
VIKING GLOBAL INVESTORS LP
Comparable rows
15/15
Latest evidence
31 Dec 2023
13F
3/4/5
Lead comparable stake: 9.3%
Showing 1-6 of 15 holder rows.
Quick read
VIKING GLOBAL INVESTORS LP leads the comparable SEC ownership view at 9.3%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens VIKING GLOBAL INVESTORS LP's linked filing trail.
Comparable ownership
Top 5
VIKING GLOBAL INVESTORS LP
9.3%
RA CAPITAL MANAGEMENT, L.P.
8.1%
BVF INC/IL
7.8%
BlackRock Finance, Inc.
6.7%
Venrock Adviser, LLC
6.6%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| VIKING GLOBAL INVESTORS LP |
13F
3/4/5
Company · 10%+ Owner
|
9.3%
|
$97,003,138
4,787,914 shares
|
— | 31 Dec 2023 |
| RA CAPITAL MANAGEMENT, L.P. |
13F
Company
|
8.1%
|
$84,346,655
4,163,211 shares
|
— | 31 Dec 2023 |
| BVF INC/IL |
13F
Company
|
7.8%
|
$81,190,187
4,007,413 shares
|
— | 31 Dec 2023 |
| BlackRock Finance, Inc. |
13F
Company
|
6.7%
|
$70,192,532
3,464,587 shares
|
— | 31 Dec 2023 |
| Venrock Adviser, LLC |
13F
Company
|
6.6%
|
$69,370,868
3,424,031 shares
|
— | 31 Dec 2023 |
| Janus Henderson Group Ltd. |
13F
Company
|
6%
|
$62,681,862
3,093,296 shares
|
— | 31 Dec 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
146
Shares
56,228,706
Rows available
146
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2024 vs Q1 2024 Across Filers
Q1 2024 holders
146
Q1 2024 holders
146
Holder diff
0
| Investor | Q1 2024 Shares | Q1 2024 Shares | Share Diff | Share Chg % | Q1 2024 value | Q1 2024 value | Value change | Value Chg % |
|---|